Efficacy Of N-Acetyl-Cysteine as Adjuvant Therapy for Diabetic Foot Osteomyelitis: An Open-Label Randomized Controlled Trial
Archives of Iranian Medicine · 2025
DOI: 10.34172/aim.33355 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Archives of Iranian Medicine, 2025. Verfasst von Laya Hooshmand Gharabagh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, Urmia University of Medical Sciences, Imam Khomeini Hospital, Urmia, Iran. Hauptthemen laut MEDLINE: Acetylcysteine, Diabetic Foot, Osteomyelitis, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Background
Biofilm formation by bacteria on the lower limb arises from reduced peripheral arterial blood flow, which can lead to the failure of antibiotic therapy or require longer duration of intravenous antibiotic therapy in diabetic foot infection-associated osteomyelitis. N-acetyl cysteine (NAC), an agent known to prevent and treat biofilm-related infections, was used as a novel strategies beside antibiotic therapy in osteomyelitis of diabetic foot with the aim of accelerating the response to antibiotic therapy regimen.
Methods
To assess the synergistic effect of NAC with antibiotic therapy, patients with diabetic foot osteomyelitis (DFO) (grade III or IV Wagner) were randomly assigned to either NAC 600 mg effervescent tablet twice daily for 2 weeks or the control group. Clinical and laboratory data, including white blood cell with differentiation and inflammatory factors (ESR and CRP) were measured at baseline (time 0), after one week and after three weeks of initiating the intervention.
Results
Fifty-three eligible patients completed the study. All evaluated infectious-related laboratory parameters showed significant reductions in the NAC group compared to control (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, School of Medicine, Urmia University of Medical Sciences, Imam Khomeini Hospital, Urmia, Iran.
- Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
- Department of Clinical Pharmacy, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.
- Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
ORCID-Profile: Laya Hooshmand Gharabagh, Mehdi Heydaroghli, Ayda Esmaeili
Zitieren
APA
Hooshmand Gharabagh, L., Heydaroghli, M., & Esmaeili, A. (2025). Efficacy Of N-Acetyl-Cysteine as Adjuvant Therapy for Diabetic Foot Osteomyelitis: An Open-Label Randomized Controlled Trial. Archives of Iranian Medicine. https://doi.org/10.34172/aim.33355
Vancouver
Hooshmand Gharabagh L, Heydaroghli M, Esmaeili A. Efficacy Of N-Acetyl-Cysteine as Adjuvant Therapy for Diabetic Foot Osteomyelitis: An Open-Label Randomized Controlled Trial. Archives of Iranian Medicine. 2025. doi:10.34172/aim.33355
BibTeX
@article{HooshmandGharabagh2025,
author = {Hooshmand Gharabagh, Laya and Heydaroghli, Mehdi and Esmaeili, Ayda},
title = {Efficacy Of N-Acetyl-Cysteine as Adjuvant Therapy for Diabetic Foot Osteomyelitis: An Open-Label Randomized Controlled Trial},
journal = {Archives of Iranian Medicine},
year = {2025},
doi = {10.34172/aim.33355}
}
EUVIMED